An important feature of ccRCC is its high vascularity nature which is mainly driven by alterations of the VHL tumor suppressor gene, leading to the activation of pro-angiogenic pathways such as the vascular endothelial growth factor (VEGF). This evidence concerns the gene VEGFA and neoplasm.